UroGen Pharma Ltd. ROCE Ratio 2011-2026 | URGN

Annual ROCE Ratio UroGen Pharma Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
118.38	1099.42	100.5	88.45	-1097.02	-126.02	-59.85	-85.67	-29.12	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1099.42	-1097.02	1.01

Quarterly ROCE Ratio UroGen Pharma Ltd.

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
163.88	78.81	-30.16	-10.41	-89.87	-57.72	22.16	126.31	62.17	90.75	104.35	221.84	202.92	128.6	59.46	-20.43	-149.02	-179.25	-137.93	-137.39	-103.25	-125.34	-108.0	-88.03	-60.3	-64.87	-75.39	-82.82	-85.67	-73.83	-50.82	-38.4	-50.08	-0.4	-8.03	-26.82	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
221.84	-179.25	-16.47

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-299.89	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-27.78	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
Deciphera Pharmaceuticals DCPH	-60.12	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	3539.01	-	-13.47 %	$ 169 M	France
AstraZeneca PLC AZN	16.47	-	-	$ 96.9 B	Britain
BioNTech SE BNTX	-7.08	$ 89.59	-	$ 21.7 B	Germany
Compugen Ltd. CGEN	23.38	$ 2.22	-	$ 207 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Coherus BioSciences CHRS	-296.87	$ 1.58	-	$ 185 M	USA
Athira Pharma ATHA	-368.0	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-41.41	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	-1.18	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-63.97	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-71.74	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-149.7	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-88.5	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-439.8	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-69.03	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-54.51	$ 29.93	-	$ 1.99 B	USA
Generation Bio Co. GBIO	-165.18	-	-	$ 344 M	USA
IMV IMV	-79.29	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Enlivex Therapeutics Ltd. ENLV	-0.65	$ 0.79	-	$ 36.1 M	Israel
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Esperion Therapeutics ESPR	-19.96	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	-3.23	$ 28.9	-	$ 778 M	USA
Cyclacel Pharmaceuticals CYCCP	-123.17	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-187.83	-	-	$ 384 M	Britain
Forte Biosciences FBRX	-115.85	$ 16.69	-	$ 216 M	USA
Gracell Biotechnologies GRCL	-45.4	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-7.7	$ 14.79	-	$ 212 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-76.42	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-146.69	$ 3.16	-	$ 5.2 M	Israel
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
CRISPR Therapeutics AG CRSP	-34.58	$ 56.95	-	$ 5.12 B	Schweiz
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Galectin Therapeutics GALT	15.7	$ 2.38	-	$ 152 M	USA